Delivery Order SPE2DB20D3103-SPE2DB21FQ0L3
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Imitrex 6 mg/0.5 ml cartridges. The delivery order contract is valued at $2,944.73 and has a completion date of August 7, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with DLA and other federal agencies, valued up to $999,999,999 and $750,000 respectively, for providing a wide range of pharmaceutical and...
- This federal contract award is for the delivery of Imitrex 6 mg/0.5 ml cartridges to the Defense Logistics Agency (DLA). The $11,598.08 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract has an ultimate completion date of September 19, 2023. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, particularly the Department of...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the delivery of Imitrex 6 mg/0.5 ml cartridges. The contract is a Delivery Order valued at $2,625.40 with a firm fixed price, and has a completion date of July 5, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025, which serves as...
- This federal contract award, valued at $56,197.85, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Imitrex 6 mg/0.5 ml cartridges, with a firm fixed price and a completion date of July 18, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00 and...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order (SPE2DB20D3101|SPE2DB24FRWG7) valued at $17,661.74. The contract is for the supply of Imitrex 6 mg/0.5 ml cartridges 0.5 ml to the Defense Logistics Agency (DLA), a defense agency. The award has an ultimate completion date of September 26, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award is for the delivery of Imitrex 6 mg/0.5 ml cartridges to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense (DoD). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company that holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025. The contract has a firm fixed price of $3,059.70 and an ultimate completion...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of IMITREX 6 MG/0.5 ML CARTRIDGES 0.5ML. The contract, valued at $4,857.20, is a firm fixed-price delivery order with a completion date of November 24, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is a delivery order for Imitrex 6 mg/0.5 ml cartridges awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $4,261.20 and is a firm fixed price agreement. The contract is funded by the Defense Logistics Agency (DLA), a defense agency that provides worldwide logistics support to the U.S. military and other government organizations. Amerisourcebergen holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $8,069.44 firm fixed-price delivery order is for the supply of Imitrex 6 mg/0.5 ml cartridges. The contract has an ultimate completion date of August 26, 2021. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
- This federal contract award is for the delivery of Imitrex 6 mg/0.5 ml cartridges to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $2,479.51 and was awarded on September 24, 2021, with a completion date of September 27, 2021. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical,...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB21FQ0L3Delivery Order
This federal contract award is for the delivery of Imitrex 6 mg/0.5 ml cartridges to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distribution company. The award has a ceiling value of $5,065.90 and an ultimate completion date of August 27, 2021. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. This contract award is likely a delivery order under that larger IDC. The contract does not have a set-aside designation, indicating it was awarded through full and open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.1k | 8/26/21 |